Crohn’s Disease with Comorbidites of Syndrome of Inappropriate Anti Diuretic Hormone (SIADH) caused by Pulmonary Tuberculosis

Rios Steven(1), Saptino Miro(2), Arnelis .(3), Vesri Yoga(4), Deka Viotra(5), Dwitya Elvira(6), Wahyudi .(7),


(1) Faculty of Medicine, Universitas Andalas, Padang
(2) Departement of Internal Medicine, Faculty of Medicine, Universitas Andalas, Dr. M Djamil Padang National General Hospital, Padang
(3) Departement of Internal Medicine, Faculty of Medicine, Universitas Andalas, Dr. M Djamil Padang National General Hospital, Padang
(4) Departement of Internal Medicine, Faculty of Medicine, Universitas Andalas, Dr. M Djamil Padang National General Hospital, Padang
(5) Departement of Internal Medicine, Faculty of Medicine, Universitas Andalas, Dr. M Djamil Padang National General Hospital, Padang
(6) Departement of Internal Medicine, Faculty of Medicine, Universitas Andalas, Dr. M Djamil Padang National General Hospital, Padang
(7) Departement of Internal Medicine, Faculty of Medicine, Universitas Andalas, Dr. M Djamil Padang National General Hospital, Padang
Corresponding Author

Abstract


Crohn's disease is an inflammatory condition of the intestines characterized by lesions that can affect the entire digestive tract from the mouth to the anus. Globally, the prevalence of inflammatory bowel disease has increased over the past 20 years, rising from 3.32 million cases in 1990 to 4.9 million cases in 2019. Previously, the management of Crohn’s disease followed the step-up therapy approach; however, this method led to higher recurrence rates. The current approach utilizes top-down therapy, as research data indicate that the remission rate is 57% with top-down therapy compared to 25% with step-up therapy. Syndrome of Inappropriate Antidiuretic Hormone (SIADH) can be caused by pulmonary tuberculosis. A 44-year-old male patient was diagnosed with Crohn’s disease based on a colonoscopy examination, which suggested chronic active colitis with mild activity and crypt distortion consistent with Crohn’s disease. An esophagogastroduodenoscopy (EGD) revealed chronic gastritis, while a histopathological examination of the colon confirmed findings consistent with Crohn’s disease. The diagnosis of pulmonary tuberculosis was established using a rapid molecular test (TCM) with positive results. Hyponatremia with hypoosmolar euvolemia was diagnosed based on serum sodium levels of 128 mmol/L, serum osmolality of 269 mosmol/L, urine osmolality of 288 mosmol/L, and urine sodium of 73 mosmol/L. Treatment included 5-ASA and anti-tuberculosis medications. Crohn’s disease increases morbidity rates and is not limited to developing countries. It is caused by immune system dysregulation, which can predispose patients to secondary infections such as tuberculosis. Pulmonary tuberculosis, in turn, can lead to SIADH.

Keywords: Crohn’s disease, pulmonary tuberculosis, SIADHTop of Form


Keywords


Crohn’s disease, pulmonary tuberculosis, SIADH

References


Desai D, Dhoble P. Editorial: Rapidly changing epidemiology of inflammatory bowel disease – time to gear up for the challenge before it is too late. IJG. 2023;1:1-3.

Fatahi DA, Saad A, Asmari A, Bukhari GA. Crohn’s Disease: Pathophysiology and Management. 2018 Jan;2004-2007.

Perkumpulan Gastroenterologi Indonesia. Konsensus nasional penatalaksanaan inflamatory bowel disease (IBD) di Indonesia (revisi 2019). PGI: Jakarta; 2019.

Asadollahi K, Beeching N, Gill G. Hyponatraemia as a risk factor for hospital mortality. 2006;99(12):877–80.

Lee P, Ho KK. Hyponatremia in pulmonary TB: evidence of ectopic antidiuretic hormone production. Chest. 2010;137(1):207-8.

Jagtap N, Banerjee RA. Clinician Guide for day to day practice. AIG IBD manual. Microlabs Limited; 2018. p. 107-123.

Tsui JJ, Huynh HQ. Is top down therapy a more effective alternative to conventional step-up therapy for Crohn’s disease? Ann Gastroenterol. 2018;31:1-12.

Lee D, Albenberg L, Compher C, Baldassano R, Piccoli D, Lewis JD, et al. Diet in the Pathogenesis and Treatment of Inflammatory Bowel Diseases. Gastroenterology. 2015 May 1;148(6):1087-106.

Ng SC, Tang W, Ching JY, Wong M, Chow CM, Hui AJ, et al. Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn's and colitis epidemiology study. Gastroenterology. 2013;145(1):158-65.

Durchschein F, Petritsch W, Hammer HF. Diet therapy for inflammatory bowel diseases: the established and the new. World J Gastroenterol. 2016;22(7):2179-94.

Regueiro MD, Greer JB, Hanauer SB. Established management paradigms in IBD: treatment targets and therapeutic tools. Am J Gastroenterol Suppl. 2016;3:8-16.

Roushan N, Ebrahimi Daryani N, Azizi Z, Pournaghshband H, Niksirat A. Differentiation of Crohn’s disease and ulcerative colitis using intestinal wall thickness of the colon: A Diagnostic accuracy study of endoscopic ultrasonography. Med J Islam Repub Iran. 2019 Jun 19;33:57. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708083/

Porter RJ, Kalla R, Ho GT. Ulcerative colitis: Recent advances in the understanding of disease pathogenesis. 2020.

Nagra N, Dang S. Protein Losing Enteropathy [Internet]. Treasure Island (FL): StatPearls Publishing; 2020.

Bernstein C, Eliakim A, Fedail S, Fried M, Gearry R, Goh KL, et al. Inflammatory Bowel Disease. WGO Global Guidelines. 2015.


Full Text: PDF

Article Metrics

Abstract View : 41 times
PDF Download : 22 times

DOI: 10.24871/261202588-92

Refbacks

  • There are currently no refbacks.